• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention.

作者信息

Sharma Samin K

出版信息

Am J Cardiol. 2004 Feb 15;93(4):524-5. doi: 10.1016/j.amjcard.2003.07.051.

DOI:10.1016/j.amjcard.2003.07.051
PMID:14969645
Abstract
摘要

相似文献

1
A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention.血小板糖蛋白IIb/IIIa抑制剂治疗对经皮冠状动脉介入术后院内结局影响的倾向性分析
Am J Cardiol. 2004 Feb 15;93(4):524-5. doi: 10.1016/j.amjcard.2003.07.051.
2
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?经皮冠状动脉血运重建术中血小板糖蛋白IIb/IIIa抑制：还有哪些需要证实？
Eur Heart J. 2000 Jun;21(11):863-7. doi: 10.1053/euhj.1999.1975.
3
Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Am Heart J. 2006 Nov;152(5):876-81. doi: 10.1016/j.ahj.2006.04.035.
4
[Glycoprotein (GP) IIb/IIIa platelet inhibitors in acute ischemic syndrome and percutaneous coronary intervention].急性缺血综合征和经皮冠状动脉介入治疗中的糖蛋白（GP）IIb/IIIa血小板抑制剂
Arq Bras Cardiol. 1998 Nov;71(5):725-34. doi: 10.1590/s0066-782x1998001100015.
5
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.阿昔单抗血小板糖蛋白IIb/IIIa阻断时代经皮冠状动脉介入治疗期间的冠状动脉穿孔：经皮处理算法
Catheter Cardiovasc Interv. 2001 Mar;52(3):279-86. doi: 10.1002/ccd.1065.
6
Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials.氯吡格雷预处理后接受经皮冠状动脉介入治疗患者中糖蛋白IIb/IIIa抑制剂的效果：随机试验的荟萃分析
Crit Pathw Cardiol. 2008 Mar;7(1):5-10. doi: 10.1097/HPC.0b013e318163ebc9.
7
Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
J Invasive Cardiol. 2002 Dec;14 Suppl E:1E.
8
Glycoprotein IIb/IIIa inhibitors.糖蛋白IIb/IIIa抑制剂
J Invasive Cardiol. 2004 Jul;16(7 Suppl):11S-16S.
9
Local delivery of glycoprotein IIb/IIIa receptor inhibitors using drug eluting stents.使用药物洗脱支架进行糖蛋白IIb/IIIa受体抑制剂的局部递送。
Semin Interv Cardiol. 1998 Sep-Dec;3(3-4):185-90.
10
A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes.一项随机试验，评估三种不同糖蛋白IIb/IIIa拮抗剂对急性冠状动脉综合征患者糖蛋白IIb/IIIa血小板受体抑制及临床终点的影响。
Cardiovasc Ther. 2016 Oct;34(5):330-6. doi: 10.1111/1755-5922.12203.